Choi JS - Search Results

1

Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.

Han HJ, Kim MS, Cha J, Choi JS, Han KH, Seong J. Han HJ, et al. Among authors: choi js. Oncology. 2014;87 Suppl 1:82-9. doi: 10.1159/000368150. Epub 2014 Nov 22. Oncology. 2014. PMID: 25427738

2

The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism.

Oh JW, Ahn SM, Kim KS, Choi JS, Lee WJ, Kim BR. Oh JW, et al. Among authors: choi js. Yonsei Med J. 2003 Dec 30;44(6):1053-8. doi: 10.3349/ymj.2003.44.6.1053. Yonsei Med J. 2003. PMID: 14703616 Free article.

3

The actual five-year survival rate of hepatocellular carcinoma patients after curative resection.

Lee JG, Kang CM, Park JS, Kim KS, Yoon DS, Choi JS, Lee WJ, Kim BR. Lee JG, et al. Among authors: choi js. Yonsei Med J. 2006 Feb 28;47(1):105-12. doi: 10.3349/ymj.2006.47.1.105. Yonsei Med J. 2006. PMID: 16502491 Free PMC article.

4

Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.

Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR. Park JS, et al. Among authors: choi js. J Surg Oncol. 2007 Mar 15;95(4):286-90. doi: 10.1002/jso.20665. J Surg Oncol. 2007. PMID: 17326125

5

What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma?

Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR. Park JS, et al. Among authors: choi js. J Surg Oncol. 2007 Jul 1;96(1):32-6. doi: 10.1002/jso.20773. J Surg Oncol. 2007. PMID: 17345596

6

DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.

Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN. Oh BK, et al. Int J Mol Med. 2007 Jul;20(1):65-73. Int J Mol Med. 2007. PMID: 17549390

7

Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?

Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. Choi GH, et al. Among authors: choi js. World J Surg. 2007 Dec;31(12):2370-7. doi: 10.1007/s00268-007-9245-6. World J Surg. 2007. PMID: 17912587

8

Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.

Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. Choi GH, et al. Among authors: choi js. Ann Surg Oncol. 2008 Feb;15(2):618-29. doi: 10.1245/s10434-007-9671-6. Epub 2007 Nov 15. Ann Surg Oncol. 2008. PMID: 18004628

9

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

Kim BK, Park JY, Kim DY, Kim JK, Kim KS, Choi JS, Moon BS, Han KH, Chon CY, Moon YM, Ahn SH. Kim BK, et al. Among authors: choi js. Liver Int. 2008 Mar;28(3):393-401. doi: 10.1111/j.1478-3231.2007.01625.x. Epub 2007 Nov 19. Liver Int. 2008. PMID: 18028321

10

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.

Kim BK, Han KH, Park YN, Park MS, Kim KS, Choi JS, Moon BS, Chon CY, Moon YM, Ahn SH. Kim BK, et al. Among authors: choi js. J Surg Oncol. 2008 Mar 1;97(3):246-52. doi: 10.1002/jso.20953. J Surg Oncol. 2008. PMID: 18095300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,495 results

Search Page

Filters